SCHEMBL14899770

SCHEMBL14899770

CC(C)C(=O)OCC1(COc2c(N3CCNCC3)cnn(-c3cc(F)cc(F)c3)c2=O)CC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCHR1 Q99705 1/20 0.33
▸ USP2 O75604 3/20 0.31
▸ ALDH1A1 P00352 3/20 0.31
▸ CYP1A2 P05177 3/20 0.31
▸ CYP3A4 P08684 3/20 0.31
▸ CASP1 P29466 3/20 0.31
▸ CASP7 P55210 3/20 0.31
▸ HIF1A Q16665 3/20 0.31
▸ GLA P06280 2/20 0.31
▸ CYP2C9 P11712 2/20 0.31
▸ HSD17B10 Q99714 2/20 0.31
▸ HPGD P15428 1/20 0.31
▸ SLC2A1 P11166 1/20 0.31
▸ SLC2A3 P11169 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ HTR6 P50406 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ HTR1A P08908 1/20 0.31
▸ SLC6A2 P23975 1/20 0.31
▸ SLC6A4 P31645 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17058285 0.89 HTR1A (0.33) MCHR1USP2ALDH1A1CYP1A2CYP3A4
SCHEMBL11944569 0.87 POLB (0.34) MCHR1ALDH1A1CYP3A4
SCHEMBL11946126 0.87 USP2 (0.34) MCHR1USP2ALDH1A1CYP1A2CYP3A4
SCHEMBL17058101 0.86 HTR1A (0.33) MCHR1USP2ALDH1A1CYP1A2CYP3A4
SCHEMBL14899899 0.83 USP2 (0.35) MCHR1USP2ALDH1A1CYP1A2CYP3A4
SCHEMBL11944568 0.82 MAPT (0.40) ALDH1A1CYP3A4TSHR
SCHEMBL11944582 0.81 MAPT (0.34) MCHR1CYP3A4TSHR
SCHEMBL14899804 0.81 CTSK (0.35) MCHR1SLC2A1SLC2A3TP53JAK2
SCHEMBL14080926 0.81 MCHR1 (0.30) MCHR1
SCHEMBL11945257 0.80 POLB (0.34) MCHR1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2586778-A2 Pyridazinone derivatives useful as glucan synthase inhibitors Merck Sharp & Dohme Corp. (US) 2013-05-01 — — EP disclosed
Send feedback